Table 1.
Patients characteristics and baseline data (FAS) stratified by two factors
| Characteristics | Factor 1 | Factor 2 | ||
|---|---|---|---|---|
| LC, n=62 | SO, n=53 | Standard Control, n=57 | Strict Control, n=58 | |
| No. (women) | 62 (21) | 53 (17) | 57 (20) | 58 (18) |
| Age, yr | 62.9±10.1 | 60.7±11.0 | 61.3±10.6 | 62.4±10.5 |
| CACs | 680 [340–2418] | 824 [224–1513] | 891 [257–1581] | 711 [319–2270] |
| Phosphate, mg/dl | 5.98±1.16 | 6.00±0.75 | 6.04±1.16 | 5.95±0.80 |
| Calcium, mg/dl | 8.74±0.70 | 8.91±0.69 | 8.90±0.67 | 8.73±0.71 |
| Magnesium, mg/dl | 2.56±0.35 | 2.64±0.37 | 2.59±0.39 | 2.61±0.33 |
| TSAT, % | 27.4±12.4 | 22.6±9.0 | 23.8±10.9 | 26.6±11.5 |
| Ferritin, ng/ml | 71 [39–126] | 59 [29–135] | 45 [30–114] | 89 [35–146] |
| Intact PTH, pg/ml | 137 [99–187] | 124 [88–178] | 132 [105–216] | 130 [84–179] |
| Intact FGF-23, pg/ml | 5225 [2595–12,325] | 5275 [2258–10,600] | 6840 [2772–13,800] | 4395 [2070–10,325] |
| Past history of CVD, % | 25.8 | 43.4 | 35.1 | 32.8 |
| Diabetes mellitus, % | 38.7 | 50.9 | 38.6 | 50.8 |
| Dyslipidemia, % | 45.2 | 43.4 | 45.6 | 43.1 |
| Hypertension, % | 90.3 | 84.9 | 91.2 | 84.5 |
| Active vitamin D prescription, % | 66.1 | 66.0 | 68.4 | 64.0 |
| Calcimimetics prescription, % | 35.5 | 32.1 | 38.6 | 29.3 |
Data are on the basis of full set analysis. Continuous variables are presented as mean ± SD or median [IQR]. Active vitamin D included oral calcitriol, alfacalcidol, and intravenous maxacalcitol and calcitriol.